Comment by junofan
3 years ago
It’s unfair to call treatments untested. Medications are tested extensively. The FDA could work with sponsors to come up with a range of risk profiles and expand access.
3 years ago
It’s unfair to call treatments untested. Medications are tested extensively. The FDA could work with sponsors to come up with a range of risk profiles and expand access.
> The FDA could work with sponsors to come up with a range of risk profiles and expand access.
They indeed do this and have various avenues for treatments to be approved on expedited timelines.
I agree: not completely untested, but not tested sufficiently to get an FDA approval. They show early promising results.
BTW people picking such experimental treatments would provide important data points.